Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial)

Ticagrelor no more effective and less well-tolerated than clopidogrel in patients with PAD (EUCLID trial) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central